<p>Explore the latest scientific innovations in biotechnology, and novel business and financing models for commercializing them.</p>
Biotech startups are a high-risk venture and many do not reach the final line. Experts explain what the most common reasons for failure are and what can be done to avoid them. You might ...
The Food and Drug Administration says that a new analysis indicating genome editing in cattle can have unintended consequences underscores the importance of its regulatory approach to ...
The biotech industry has often been criticized for its lack of gender diversity. While there is still a long way to go to achieve ideal levels of equality, there are more and more women ...
As Vividion execs proudly showed off an $82 million B round last spring, the startup was eager to discuss 3 preclinical programs — an adaptor protein, a transcription factor and an E3 ...
There is a significant amount of work being done on cardiovascular diseases. Here’s a look at just some of the recent news.
A partnership between the UK lab automation company Arctoris and Swiss software firm Molecule aims to make it easier to share drug intellectual property in a time of declining returns in ...
The Business Development Manager (BDM) will support both the CEO of DEBRA Austria, and its Board of Trustees, by providing strategic advice on prioritization of research support …